Allegran announced this week that the U.S. Food and Drug Administration (FDA) has accepted its supplemental New Drug Application (sNDA) for AVYCAZ and has granted the sNDA priority review status. Read More »

The National Association of Chain Drug Stores (NACDS) recently named Vonnie Hampel as its new director of federal government affairs. Read More »

Endo Pharmaceuticals Inc. announced this week that BELBUCA buccal film is now available. Read More »

Acorda Therapeutics Inc. announced last week that the waiting period has expired for its tender offer for Biotie Therapies, according to an amendment to the Hart-Scott-Rodino Antitrust Improvement Act of 1976 (HSR). Read More »

Sanofi made an announcement this week to confirm that its license and development agreement with kaleo will expire later this year. Read More »

PioneerRx and TCGRx have announced that the two pharmacies will be integrating PioneerRx’s system with TCGRx’s technology. Read More »

Pfizer Inc. announced last week that the United States Food and Drug Administration (FDA) has approved the expanded use of the drug IBRANCE (palbociclib). Read More »

PrescribeWellness and SinfoniaRx have announced that the two companies have signed an agreement that will allow for the optimization of medical treatments for millions of patients nationwide. Read More »

RelayHealth Financial announced last week a comprehensive agenda for the HIMSS16 Conference and Exhibition that will aid financial leaders in the health care industry to hurdle obstacles that disturb payments when the financial and clinical processes are not interconnected. Read More »

The National Association of Chain Drug Stores (NACDS) has continued its discussions with congressional stakeholders after the release of the Covered Outpatient Drugs Final Rule by the Centers for Medicare & Medicaid Services (CMS), which would alter significantly reimbursement by pharmacies for both generic and brand name drugs distributed to Medicaid users. Read More »

CVS Health announced this week that the prescription drug trend for CVS Health pharmacy benefit management (PBM) fell from 11.8 percent in 2014 all the way down to 5 percent in 2015 despite drug prices being on the rise. Read More »

Bristol-Myers Squibb announced today that it has finalized the sale of its HIV R&D portfolio to ViiV Healthcare. Read More »

The U.S. Food and Drug Administration (FDA) has put out an alert to health care professionals about the recall of morphine sulfate 0.5 mg/mL preservative free in 0.9% sodium chloride. Read More »

Amgen and UCB announced this week positive results from the Phase 3 trial of a fracture study in postmenopausal women with osteoporosis (FRAME). Read More »

Valeritas Inc. announced last week that Endocrine Practice published a reflective study analysis titled “Clinical and Cost Effectiveness of Insulin Delivery with V-Go Disposable Insulin Delivery Device versus Multiple Daily Injections in Patients with Type 2 Diabetes Inadequately Controlled on Basal Insulin.” Read More »

McKesson announced this week that it has renewed health care IT services with Saint Anthony Hospital, based in Chicago, Illinois, and Cookeville Regional Medical Center (CRMC), located in Tennessee. Read More »

The National Association of Chain Drug Stores (NACDS) announced this week a request for proposals (RFP) that it will use to create two awards of $300,000 each for demonstration projects that will cultivate alliances across the health care platform to increase immunizations based in pharmacies. Read More »

The U.S. Food and Drug Administration (FDA) announced this week that Briviact (brivaracetam) has been approved as a treatment of epileptic seizures by being added on to other medications. Read More »

McKesson Specialty Health announced this week that the Scottsdale Area Chamber of Commerce has awarded its Reimbursement, Access & Services Solution Center the Sterling Award. Read More »

AstraZeneca and its research and development subsidiary, MedImmune, announced this week that the United States Food and Drug Administration (FDA) has granted durvalumab (MEDI4736) Breakthrough Therapy designation (BTD). Read More »